Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (SAHPRA), in collaboration with the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing either Semaglutide, Tirzepatide, or a combination...
Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) today briefed members of the media on the recall of specific batches of Citro-Soda Regular products, reaffirming its commitment to protecting public health and ensuring the safety, quality, and efficacy of all...
Pretoria, 20 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) will brief the media on the recall of specific batches of Citro-Soda Regular following a potential contamination risk identified at the Adcock Ingram Clayville manufacturing facility in Johannesburg. The recall is limited to...
The South African Health Products Regulatory Authority (SAHPRA) recently hosted a two-day workshop in Mbombela, Mpumalanga, from 24 to 25 February 2026. This event brought together healthcare workers from across the province, providing them with practical, hands-on training in medicine and vaccine safety reporting. The...
The South African Health Products Regulatory Authority (SAHPRA) reinforced its role as a champion of scientific advancement by sponsoring top achievers at the 2025 Dean’s Excellence Awards hosted by Sefako Makgatho Health Sciences University. Held on 13 February 2026 in Ga-Rankuwa, north of Pretoria, the...
Pretoria, 23 February 2026 – The South African Health Products Regulatory Authority (SAHPRA) has noted the recent Carte Blanche broadcast raising concerns, based on information from a former employee, regarding alleged Good Manufacturing Practice (GMP) non-compliance at Adcock Ingram’s manufacturing facility in Clayville, Johannesburg. SAHPRA wishes...
Pretoria, 13 February 2026 -The South African Health Products Regulatory Authority (SAHPRA) confirms that it has granted Section 21 authorisation for the importation of the Dollvet Foot and Mouth Disease (FMD) vaccine with conditions and is currently assessing an additional application for the same vaccine. Foot...
For immediate release Pretoria, 8 January 2026 - The South African Health Products Regulatory Authority (SAHPRA) has been made aware of products in the market containing Zinc picolinate (as a source material for zinc) and/or Selenium intended for use in children. Both of these ingredients have been...
Substandard and falsified medical products (SFMPs) are identified as one of the urgent global challenges of this decade. The global threat and routes to the market of SFMPs have grown exponentially with the ever-increasing demand for medical products globally. The entry of SFMPs into the...
Embargo: Immediate release Pretoria, 1 December 2025 – The South African Health Products Regulatory Authority (SAHPRA) has officially been accepted as a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), following an ICH assessment of compliance with requirements...
